Christian Öhlschlegel

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

Giuseppe Viale, Meredith M. Regan, Eugenio Maiorano et al. · Journal of Clinical Oncology · 2007 · 456 citations · Full text

Medicine, Endocrinology, Oncology +17

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Giuseppe Viale, Anita Giobbie‐Hurder, Meredith M. Regan et al. · Journal of Clinical Oncology · 2008 · 343 citations · Full text

Medicine, Oncology, Pharmacology +15

Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua et al. · JNCI Journal of the National Cancer Institute · 2008 · 250 citations · Full text

Medicine, Oncology, Breast Oncology +14

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Zsuzsanna Varga, Joachim Diebold, Corina Dommann‐Scherrer et al. · PLoS ONE · 2012 · 226 citations · Full text

Medicine, Oncology, Pathology +13

Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors—International Breast Cancer Study Group

Giuseppe Viale, Meredith M. Regan, Eugenio Maiorano et al. · Journal of Clinical Oncology · 2008 · 116 citations · Full text

Medicine, Cancer Biology, Breast Oncology +15